Drupal-Bibcite31<style face="normal" font="default" size="100%">Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia</style><style face="normal" font="default" size="100%">Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia</style>